Option chain shows key data for Immunovia's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Immunovia.

Immunovia (OTC:IMMVF) Stock, Option Chain

Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The company is currently developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer.

Comments

Immunovia

Immunovia (IMMVF) Options

Loading...

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga